Cargando…
Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives
Liver transplantation (LT) has become the best chance and a routine practice for patients with end-stage liver disease and small hepatocellular carcinoma. However, life-long immunosuppressive regimens could lead to many post-LT complications, including cancer recurrence, infections, dysmetabolic syn...
Autores principales: | Wang, Pusen, Jiang, Zhongyi, Wang, Chunguang, Liu, Xueni, Li, Hao, Xu, Dingyin, Zhong, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461870/ https://www.ncbi.nlm.nih.gov/pubmed/33013824 http://dx.doi.org/10.3389/fimmu.2020.01723 |
Ejemplares similares
-
Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population
por: Jiang, Zhongyi, et al.
Publicado: (2021) -
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
por: Wang, Pusen, et al.
Publicado: (2020) -
Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
por: Jiang, Zhongyi, et al.
Publicado: (2021) -
Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
por: Tanimine, Naoki, et al.
Publicado: (2020) -
CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target
por: Jiang, Qianwei, et al.
Publicado: (2023)